相关实验视频
Updated: Jan 11, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.1K
跨部门研究与超多药性和药物坚持相关的因素在老年人多病症和多药性
Shanthi Beglinger1, Lisa Bretagne1,2, François Volery2
1Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Drugs & aging
|November 12, 2025
概括
超过一半的超多药性老年人 (10+药物) 显示药物坚持不佳. 主要护理和社区护士可以改善药物遵守,减少药物负担.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 药物坚持对于治疗有效性和降低医疗保健成本至关重要.
- 高多药性 (≥10种药物) 在老年人中很普遍,但依从性数据有限.
- 了解影响超多药学和坚持的因素对于老年护理至关重要.
研究的目的:
- 为了确定与老年人过多药性相关的因素.
- 为了确定与超多药剂患者的药物坚持相关的因素.
- 探索超多药学和药物坚持之间的关系.
主要方法:
- 来自多中心OPERAM研究的基线数据的横截面分析.
- 包括70岁以上的多病症和多药性 (≥5种药物) 的成年人.
- 评估人口,临床和医疗保健利用数据;用于MMAS-8的坚持;采用多变量后勤回归.
主要成果:
- 51%的患者表现出高多药性;与并发病,养老院住院和高医疗利用率相关.
- 53%的多重药物治疗患者具有低/中度的坚持.
- 较低的坚持与更多的并发病相关;较高的坚持与老年和社区护理护理相关.
结论:
- 低于最佳的药物坚持是常见的老年人与超多药.
- 初级保健干预措施可能会减少过多药学.
- 社区护士的参与显示出改善药物服药能力的潜力.
相关概念视频
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226

